Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

MGI launches VisiOmics in Europe and unveils AI-enabled pathology portfolio at ECP 2026

16

Sep 2026

MGI launches VisiOmics in Europe and unveils AI-enabled pathology portfolio at ECP 2026

MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life science, today announced the European launch of VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence (mIF) staining and imaging system, at the 38th European Congress of Pathology (ECP 2026), held in Stockholm from 12 to 16 September 2026.

One brain implant could give people with paralysis a more expressive way to communicate

16

Sep 2026

One brain implant could give people with paralysis a more expressive way to communicate

Researchers showed that a single high-density ECoG implant could decode attempted speech and upper-body gestures in parallel in people with severe paralysis, allowing two participants to control a personalized full-body avatar. Training the decoders on both isolated and concurrent behaviors improved performance across contexts and reduced false activations, offering proof-of-concept evidence for more expressive multimodal BCIs.

Finnish adults eat too little of some foods and too much of others, study finds

16

Sep 2026

Finnish adults eat too little of some foods and too much of others, study finds

Analysis of dietary data from 1,655 Finnish adults found that usual food intake often differed substantially from the quantitative targets later set by the Nordic Nutrition Recommendations 2023. Plant-based foods were generally underconsumed, while red and processed meat and dairy intake frequently exceeded study targets, with adherence varying by sex, education, physical activity, age, and energy intake.

Exercise usually helps the brain. During a 15-day fast, the story was different

15

Sep 2026

Exercise usually helps the brain. During a 15-day fast, the story was different

In a 28-day controlled study of 22 healthy adults, 15 days of complete fasting produced a glucose-to-ketone metabolic shift and selectively affected attention and implicit learning while time perception remained relatively stable. Moderate-intensity exercise during early fasting was associated with poorer performance on some learning measures, while fasting also increased sleepiness and reduced calmness at some time points.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.